タンパク質阻害剤のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Protein Inhibitors Market Insights, Forecast to 2028

• レポートコード：QY2207E10482 • 出版社/出版日：QYResearch / 2022年7月 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥725,200 (USD4,900)	▷ お問い合わせ
Multi User	￥1,087,800 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,450,400 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界のタンパク質阻害剤の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にタンパク質阻害剤の世界市場のxxx％を占める「プロテインキナーゼ阻害剤」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「腫瘍」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国のタンパク質阻害剤の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのタンパク質阻害剤市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのタンパク質阻害剤市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 タンパク質阻害剤のグローバル主要メーカーには、Bayer AG、Astra Zeneca、Roche、Teva、Apotex、Novartis、Glaxosmithkline、Pfizer、Boehringer Ingelheim、F. Hoffmann-La Roche、Abbott Laboratories、Amgen Inc.、Baxter International Inc.などがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 タンパク質阻害剤市場は、種類と用途によって区分されます。世界のタンパク質阻害剤市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 プロテインキナーゼ阻害剤、モノクローナル抗体、その他 【用途別セグメント】 腫瘍、炎症性疾患、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - タンパク質阻害剤製品概要 - 種類別市場（プロテインキナーゼ阻害剤、モノクローナル抗体、その他） - 用途別市場（腫瘍、炎症性疾患、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のタンパク質阻害剤販売量予測2017-2028 - 世界のタンパク質阻害剤売上予測2017-2028 - タンパク質阻害剤の地域別販売量 - タンパク質阻害剤の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別タンパク質阻害剤販売量 - 主要メーカー別タンパク質阻害剤売上 - 主要メーカー別タンパク質阻害剤価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（プロテインキナーゼ阻害剤、モノクローナル抗体、その他） - タンパク質阻害剤の種類別販売量 - タンパク質阻害剤の種類別売上 - タンパク質阻害剤の種類別価格 ・用途別市場規模（腫瘍、炎症性疾患、その他） - タンパク質阻害剤の用途別販売量 - タンパク質阻害剤の用途別売上 - タンパク質阻害剤の用途別価格 ・北米市場 - 北米のタンパク質阻害剤市場規模（種類別、用途別） - 主要国別のタンパク質阻害剤市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのタンパク質阻害剤市場規模（種類別、用途別） - 主要国別のタンパク質阻害剤市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のタンパク質阻害剤市場規模（種類別、用途別） - 主要国別のタンパク質阻害剤市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のタンパク質阻害剤市場規模（種類別、用途別） - 主要国別のタンパク質阻害剤市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのタンパク質阻害剤市場規模（種類別、用途別） - 主要国別のタンパク質阻害剤市場規模（トルコ、サウジアラビア） ・企業情報 Bayer AG、Astra Zeneca、Roche、Teva、Apotex、Novartis、Glaxosmithkline、Pfizer、Boehringer Ingelheim、F. Hoffmann-La Roche、Abbott Laboratories、Amgen Inc.、Baxter International Inc. ・産業チェーン及び販売チャネル分析 - タンパク質阻害剤の産業チェーン分析 - タンパク質阻害剤の原材料 - タンパク質阻害剤の生産プロセス - タンパク質阻害剤の販売及びマーケティング - タンパク質阻害剤の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - タンパク質阻害剤の産業動向 - タンパク質阻害剤のマーケットドライバー - タンパク質阻害剤の課題 - タンパク質阻害剤の阻害要因 ・主な調査結果

Market Analysis and Insights: Global Protein Inhibitors Market
Due to the COVID-19 pandemic, the global Protein Inhibitors market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Protein Kinase Inhibitors accounting for % of the Protein Inhibitors global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Oncology segment is altered to an % CAGR throughout this forecast period.
China Protein Inhibitors market size is valued at US$ million in 2021, while the US and Europe Protein Inhibitors are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Protein Inhibitors landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Protein Inhibitors include Bayer AG, Astra Zeneca, Roche, Teva, Apotex, Novartis, Glaxosmithkline, Pfizer and Boehringer Ingelheim, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Protein Inhibitors Scope and Segment
Protein Inhibitors market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Protein Inhibitors market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Protein Kinase Inhibitors
Monoclonal Antibody
Others
Segment by Application
Oncology
Inflamatory Diseases
Others
By Company
Bayer AG
Astra Zeneca
Roche
Teva
Apotex
Novartis
Glaxosmithkline
Pfizer
Boehringer Ingelheim
F. Hoffmann-La Roche
Abbott Laboratories
Amgen Inc.
Baxter International Inc.
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

---

1 Study Coverage
1.1 Protein Inhibitors Product Introduction
1.2 Market by Type
1.2.1 Global Protein Inhibitors Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Protein Kinase Inhibitors
1.2.3 Monoclonal Antibody
1.2.4 Others
1.3 Market by Application
1.3.1 Global Protein Inhibitors Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Oncology
1.3.3 Inflamatory Diseases
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Protein Inhibitors Sales Estimates and Forecasts 2017-2028
2.2 Global Protein Inhibitors Revenue Estimates and Forecasts 2017-2028
2.3 Global Protein Inhibitors Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Protein Inhibitors Sales by Region
2.4.1 Global Protein Inhibitors Sales by Region (2017-2022)
2.4.2 Global Sales Protein Inhibitors by Region (2023-2028)
2.5 Global Protein Inhibitors Revenue by Region
2.5.1 Global Protein Inhibitors Revenue by Region (2017-2022)
2.5.2 Global Protein Inhibitors Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Protein Inhibitors Sales by Manufacturers
3.1.1 Global Top Protein Inhibitors Manufacturers by Sales (2017-2022)
3.1.2 Global Protein Inhibitors Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Protein Inhibitors in 2021
3.2 Global Protein Inhibitors Revenue by Manufacturers
3.2.1 Global Protein Inhibitors Revenue by Manufacturers (2017-2022)
3.2.2 Global Protein Inhibitors Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Protein Inhibitors Revenue in 2021
3.3 Global Protein Inhibitors Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Protein Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Protein Inhibitors Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Protein Inhibitors Sales by Type
4.1.1 Global Protein Inhibitors Historical Sales by Type (2017-2022)
4.1.2 Global Protein Inhibitors Forecasted Sales by Type (2023-2028)
4.1.3 Global Protein Inhibitors Sales Market Share by Type (2017-2028)
4.2 Global Protein Inhibitors Revenue by Type
4.2.1 Global Protein Inhibitors Historical Revenue by Type (2017-2022)
4.2.2 Global Protein Inhibitors Forecasted Revenue by Type (2023-2028)
4.2.3 Global Protein Inhibitors Revenue Market Share by Type (2017-2028)
4.3 Global Protein Inhibitors Price by Type
4.3.1 Global Protein Inhibitors Price by Type (2017-2022)
4.3.2 Global Protein Inhibitors Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Protein Inhibitors Sales by Application
5.1.1 Global Protein Inhibitors Historical Sales by Application (2017-2022)
5.1.2 Global Protein Inhibitors Forecasted Sales by Application (2023-2028)
5.1.3 Global Protein Inhibitors Sales Market Share by Application (2017-2028)
5.2 Global Protein Inhibitors Revenue by Application
5.2.1 Global Protein Inhibitors Historical Revenue by Application (2017-2022)
5.2.2 Global Protein Inhibitors Forecasted Revenue by Application (2023-2028)
5.2.3 Global Protein Inhibitors Revenue Market Share by Application (2017-2028)
5.3 Global Protein Inhibitors Price by Application
5.3.1 Global Protein Inhibitors Price by Application (2017-2022)
5.3.2 Global Protein Inhibitors Price Forecast by Application (2023-2028)
6 North America
6.1 North America Protein Inhibitors Market Size by Type
6.1.1 North America Protein Inhibitors Sales by Type (2017-2028)
6.1.2 North America Protein Inhibitors Revenue by Type (2017-2028)
6.2 North America Protein Inhibitors Market Size by Application
6.2.1 North America Protein Inhibitors Sales by Application (2017-2028)
6.2.2 North America Protein Inhibitors Revenue by Application (2017-2028)
6.3 North America Protein Inhibitors Market Size by Country
6.3.1 North America Protein Inhibitors Sales by Country (2017-2028)
6.3.2 North America Protein Inhibitors Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Protein Inhibitors Market Size by Type
7.1.1 Europe Protein Inhibitors Sales by Type (2017-2028)
7.1.2 Europe Protein Inhibitors Revenue by Type (2017-2028)
7.2 Europe Protein Inhibitors Market Size by Application
7.2.1 Europe Protein Inhibitors Sales by Application (2017-2028)
7.2.2 Europe Protein Inhibitors Revenue by Application (2017-2028)
7.3 Europe Protein Inhibitors Market Size by Country
7.3.1 Europe Protein Inhibitors Sales by Country (2017-2028)
7.3.2 Europe Protein Inhibitors Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Protein Inhibitors Market Size by Type
8.1.1 Asia Pacific Protein Inhibitors Sales by Type (2017-2028)
8.1.2 Asia Pacific Protein Inhibitors Revenue by Type (2017-2028)
8.2 Asia Pacific Protein Inhibitors Market Size by Application
8.2.1 Asia Pacific Protein Inhibitors Sales by Application (2017-2028)
8.2.2 Asia Pacific Protein Inhibitors Revenue by Application (2017-2028)
8.3 Asia Pacific Protein Inhibitors Market Size by Region
8.3.1 Asia Pacific Protein Inhibitors Sales by Region (2017-2028)
8.3.2 Asia Pacific Protein Inhibitors Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Protein Inhibitors Market Size by Type
9.1.1 Latin America Protein Inhibitors Sales by Type (2017-2028)
9.1.2 Latin America Protein Inhibitors Revenue by Type (2017-2028)
9.2 Latin America Protein Inhibitors Market Size by Application
9.2.1 Latin America Protein Inhibitors Sales by Application (2017-2028)
9.2.2 Latin America Protein Inhibitors Revenue by Application (2017-2028)
9.3 Latin America Protein Inhibitors Market Size by Country
9.3.1 Latin America Protein Inhibitors Sales by Country (2017-2028)
9.3.2 Latin America Protein Inhibitors Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Protein Inhibitors Market Size by Type
10.1.1 Middle East and Africa Protein Inhibitors Sales by Type (2017-2028)
10.1.2 Middle East and Africa Protein Inhibitors Revenue by Type (2017-2028)
10.2 Middle East and Africa Protein Inhibitors Market Size by Application
10.2.1 Middle East and Africa Protein Inhibitors Sales by Application (2017-2028)
10.2.2 Middle East and Africa Protein Inhibitors Revenue by Application (2017-2028)
10.3 Middle East and Africa Protein Inhibitors Market Size by Country
10.3.1 Middle East and Africa Protein Inhibitors Sales by Country (2017-2028)
10.3.2 Middle East and Africa Protein Inhibitors Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Bayer AG
11.1.1 Bayer AG Corporation Information
11.1.2 Bayer AG Overview
11.1.3 Bayer AG Protein Inhibitors Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Bayer AG Protein Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Bayer AG Recent Developments
11.2 Astra Zeneca
11.2.1 Astra Zeneca Corporation Information
11.2.2 Astra Zeneca Overview
11.2.3 Astra Zeneca Protein Inhibitors Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Astra Zeneca Protein Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Astra Zeneca Recent Developments
11.3 Roche
11.3.1 Roche Corporation Information
11.3.2 Roche Overview
11.3.3 Roche Protein Inhibitors Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Roche Protein Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Roche Recent Developments
11.4 Teva
11.4.1 Teva Corporation Information
11.4.2 Teva Overview
11.4.3 Teva Protein Inhibitors Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Teva Protein Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Teva Recent Developments
11.5 Apotex
11.5.1 Apotex Corporation Information
11.5.2 Apotex Overview
11.5.3 Apotex Protein Inhibitors Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Apotex Protein Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Apotex Recent Developments
11.6 Novartis
11.6.1 Novartis Corporation Information
11.6.2 Novartis Overview
11.6.3 Novartis Protein Inhibitors Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Novartis Protein Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Novartis Recent Developments
11.7 Glaxosmithkline
11.7.1 Glaxosmithkline Corporation Information
11.7.2 Glaxosmithkline Overview
11.7.3 Glaxosmithkline Protein Inhibitors Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Glaxosmithkline Protein Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Glaxosmithkline Recent Developments
11.8 Pfizer
11.8.1 Pfizer Corporation Information
11.8.2 Pfizer Overview
11.8.3 Pfizer Protein Inhibitors Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Pfizer Protein Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Pfizer Recent Developments
11.9 Boehringer Ingelheim
11.9.1 Boehringer Ingelheim Corporation Information
11.9.2 Boehringer Ingelheim Overview
11.9.3 Boehringer Ingelheim Protein Inhibitors Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Boehringer Ingelheim Protein Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Boehringer Ingelheim Recent Developments
11.10 F. Hoffmann-La Roche
11.10.1 F. Hoffmann-La Roche Corporation Information
11.10.2 F. Hoffmann-La Roche Overview
11.10.3 F. Hoffmann-La Roche Protein Inhibitors Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 F. Hoffmann-La Roche Protein Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 F. Hoffmann-La Roche Recent Developments
11.11 Abbott Laboratories
11.11.1 Abbott Laboratories Corporation Information
11.11.2 Abbott Laboratories Overview
11.11.3 Abbott Laboratories Protein Inhibitors Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Abbott Laboratories Protein Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Abbott Laboratories Recent Developments
11.12 Amgen Inc.
11.12.1 Amgen Inc. Corporation Information
11.12.2 Amgen Inc. Overview
11.12.3 Amgen Inc. Protein Inhibitors Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Amgen Inc. Protein Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Amgen Inc. Recent Developments
11.13 Baxter International Inc.
11.13.1 Baxter International Inc. Corporation Information
11.13.2 Baxter International Inc. Overview
11.13.3 Baxter International Inc. Protein Inhibitors Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Baxter International Inc. Protein Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Baxter International Inc. Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Protein Inhibitors Industry Chain Analysis
12.2 Protein Inhibitors Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Protein Inhibitors Production Mode & Process
12.4 Protein Inhibitors Sales and Marketing
12.4.1 Protein Inhibitors Sales Channels
12.4.2 Protein Inhibitors Distributors
12.5 Protein Inhibitors Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Protein Inhibitors Industry Trends
13.2 Protein Inhibitors Market Drivers
13.3 Protein Inhibitors Market Challenges
13.4 Protein Inhibitors Market Restraints
14 Key Findings in The Global Protein Inhibitors Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Protein Inhibitors Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Protein Kinase Inhibitors
Table 3. Major Manufacturers of Monoclonal Antibody
Table 4. Major Manufacturers of Others
Table 5. Global Protein Inhibitors Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Protein Inhibitors Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Protein Inhibitors Sales by Region (2017-2022) & (K Units)
Table 8. Global Protein Inhibitors Sales Market Share by Region (2017-2022)
Table 9. Global Protein Inhibitors Sales by Region (2023-2028) & (K Units)
Table 10. Global Protein Inhibitors Sales Market Share by Region (2023-2028)
Table 11. Global Protein Inhibitors Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Protein Inhibitors Revenue Market Share by Region (2017-2022)
Table 13. Global Protein Inhibitors Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global Protein Inhibitors Revenue Market Share by Region (2023-2028)
Table 15. Global Protein Inhibitors Sales by Manufacturers (2017-2022) & (K Units)
Table 16. Global Protein Inhibitors Sales Share by Manufacturers (2017-2022)
Table 17. Global Protein Inhibitors Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global Protein Inhibitors Revenue Share by Manufacturers (2017-2022)
Table 19. Protein Inhibitors Price by Manufacturers (2017-2022) &(US$/Unit)
Table 20. Global Protein Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Protein Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Protein Inhibitors as of 2021)
Table 22. Protein Inhibitors Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Protein Inhibitors Product Offered
Table 24. Date of Manufacturers Enter into Protein Inhibitors Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Protein Inhibitors Sales by Type (2017-2022) & (K Units)
Table 27. Global Protein Inhibitors Sales by Type (2023-2028) & (K Units)
Table 28. Global Protein Inhibitors Sales Share by Type (2017-2022)
Table 29. Global Protein Inhibitors Sales Share by Type (2023-2028)
Table 30. Global Protein Inhibitors Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global Protein Inhibitors Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global Protein Inhibitors Revenue Share by Type (2017-2022)
Table 33. Global Protein Inhibitors Revenue Share by Type (2023-2028)
Table 34. Protein Inhibitors Price by Type (2017-2022) & (US$/Unit)
Table 35. Global Protein Inhibitors Price Forecast by Type (2023-2028) & (US$/Unit)
Table 36. Global Protein Inhibitors Sales by Application (2017-2022) & (K Units)
Table 37. Global Protein Inhibitors Sales by Application (2023-2028) & (K Units)
Table 38. Global Protein Inhibitors Sales Share by Application (2017-2022)
Table 39. Global Protein Inhibitors Sales Share by Application (2023-2028)
Table 40. Global Protein Inhibitors Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global Protein Inhibitors Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global Protein Inhibitors Revenue Share by Application (2017-2022)
Table 43. Global Protein Inhibitors Revenue Share by Application (2023-2028)
Table 44. Protein Inhibitors Price by Application (2017-2022) & (US$/Unit)
Table 45. Global Protein Inhibitors Price Forecast by Application (2023-2028) & (US$/Unit)
Table 46. North America Protein Inhibitors Sales by Type (2017-2022) & (K Units)
Table 47. North America Protein Inhibitors Sales by Type (2023-2028) & (K Units)
Table 48. North America Protein Inhibitors Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America Protein Inhibitors Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America Protein Inhibitors Sales by Application (2017-2022) & (K Units)
Table 51. North America Protein Inhibitors Sales by Application (2023-2028) & (K Units)
Table 52. North America Protein Inhibitors Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America Protein Inhibitors Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America Protein Inhibitors Sales by Country (2017-2022) & (K Units)
Table 55. North America Protein Inhibitors Sales by Country (2023-2028) & (K Units)
Table 56. North America Protein Inhibitors Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America Protein Inhibitors Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe Protein Inhibitors Sales by Type (2017-2022) & (K Units)
Table 59. Europe Protein Inhibitors Sales by Type (2023-2028) & (K Units)
Table 60. Europe Protein Inhibitors Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe Protein Inhibitors Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe Protein Inhibitors Sales by Application (2017-2022) & (K Units)
Table 63. Europe Protein Inhibitors Sales by Application (2023-2028) & (K Units)
Table 64. Europe Protein Inhibitors Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe Protein Inhibitors Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe Protein Inhibitors Sales by Country (2017-2022) & (K Units)
Table 67. Europe Protein Inhibitors Sales by Country (2023-2028) & (K Units)
Table 68. Europe Protein Inhibitors Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe Protein Inhibitors Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific Protein Inhibitors Sales by Type (2017-2022) & (K Units)
Table 71. Asia Pacific Protein Inhibitors Sales by Type (2023-2028) & (K Units)
Table 72. Asia Pacific Protein Inhibitors Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific Protein Inhibitors Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific Protein Inhibitors Sales by Application (2017-2022) & (K Units)
Table 75. Asia Pacific Protein Inhibitors Sales by Application (2023-2028) & (K Units)
Table 76. Asia Pacific Protein Inhibitors Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific Protein Inhibitors Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific Protein Inhibitors Sales by Region (2017-2022) & (K Units)
Table 79. Asia Pacific Protein Inhibitors Sales by Region (2023-2028) & (K Units)
Table 80. Asia Pacific Protein Inhibitors Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific Protein Inhibitors Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America Protein Inhibitors Sales by Type (2017-2022) & (K Units)
Table 83. Latin America Protein Inhibitors Sales by Type (2023-2028) & (K Units)
Table 84. Latin America Protein Inhibitors Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America Protein Inhibitors Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America Protein Inhibitors Sales by Application (2017-2022) & (K Units)
Table 87. Latin America Protein Inhibitors Sales by Application (2023-2028) & (K Units)
Table 88. Latin America Protein Inhibitors Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America Protein Inhibitors Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America Protein Inhibitors Sales by Country (2017-2022) & (K Units)
Table 91. Latin America Protein Inhibitors Sales by Country (2023-2028) & (K Units)
Table 92. Latin America Protein Inhibitors Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America Protein Inhibitors Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa Protein Inhibitors Sales by Type (2017-2022) & (K Units)
Table 95. Middle East and Africa Protein Inhibitors Sales by Type (2023-2028) & (K Units)
Table 96. Middle East and Africa Protein Inhibitors Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa Protein Inhibitors Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Protein Inhibitors Sales by Application (2017-2022) & (K Units)
Table 99. Middle East and Africa Protein Inhibitors Sales by Application (2023-2028) & (K Units)
Table 100. Middle East and Africa Protein Inhibitors Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Protein Inhibitors Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Protein Inhibitors Sales by Country (2017-2022) & (K Units)
Table 103. Middle East and Africa Protein Inhibitors Sales by Country (2023-2028) & (K Units)
Table 104. Middle East and Africa Protein Inhibitors Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Protein Inhibitors Revenue by Country (2023-2028) & (US$ Million)
Table 106. Bayer AG Corporation Information
Table 107. Bayer AG Description and Major Businesses
Table 108. Bayer AG Protein Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 109. Bayer AG Protein Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. Bayer AG Recent Developments
Table 111. Astra Zeneca Corporation Information
Table 112. Astra Zeneca Description and Major Businesses
Table 113. Astra Zeneca Protein Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 114. Astra Zeneca Protein Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Astra Zeneca Recent Developments
Table 116. Roche Corporation Information
Table 117. Roche Description and Major Businesses
Table 118. Roche Protein Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 119. Roche Protein Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Roche Recent Developments
Table 121. Teva Corporation Information
Table 122. Teva Description and Major Businesses
Table 123. Teva Protein Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 124. Teva Protein Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Teva Recent Developments
Table 126. Apotex Corporation Information
Table 127. Apotex Description and Major Businesses
Table 128. Apotex Protein Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 129. Apotex Protein Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Apotex Recent Developments
Table 131. Novartis Corporation Information
Table 132. Novartis Description and Major Businesses
Table 133. Novartis Protein Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 134. Novartis Protein Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Novartis Recent Developments
Table 136. Glaxosmithkline Corporation Information
Table 137. Glaxosmithkline Description and Major Businesses
Table 138. Glaxosmithkline Protein Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 139. Glaxosmithkline Protein Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Glaxosmithkline Recent Developments
Table 141. Pfizer Corporation Information
Table 142. Pfizer Description and Major Businesses
Table 143. Pfizer Protein Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 144. Pfizer Protein Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. Pfizer Recent Developments
Table 146. Boehringer Ingelheim Corporation Information
Table 147. Boehringer Ingelheim Description and Major Businesses
Table 148. Boehringer Ingelheim Protein Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 149. Boehringer Ingelheim Protein Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 150. Boehringer Ingelheim Recent Developments
Table 151. F. Hoffmann-La Roche Corporation Information
Table 152. F. Hoffmann-La Roche Description and Major Businesses
Table 153. F. Hoffmann-La Roche Protein Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 154. F. Hoffmann-La Roche Protein Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 155. F. Hoffmann-La Roche Recent Developments
Table 156. Abbott Laboratories Corporation Information
Table 157. Abbott Laboratories Description and Major Businesses
Table 158. Abbott Laboratories Protein Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 159. Abbott Laboratories Protein Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 160. Abbott Laboratories Recent Developments
Table 161. Amgen Inc. Corporation Information
Table 162. Amgen Inc. Description and Major Businesses
Table 163. Amgen Inc. Protein Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 164. Amgen Inc. Protein Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 165. Amgen Inc. Recent Developments
Table 166. Baxter International Inc. Corporation Information
Table 167. Baxter International Inc. Description and Major Businesses
Table 168. Baxter International Inc. Protein Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 169. Baxter International Inc. Protein Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 170. Baxter International Inc. Recent Developments
Table 171. Key Raw Materials Lists
Table 172. Raw Materials Key Suppliers Lists
Table 173. Protein Inhibitors Distributors List
Table 174. Protein Inhibitors Customers List
Table 175. Protein Inhibitors Market Trends
Table 176. Protein Inhibitors Market Drivers
Table 177. Protein Inhibitors Market Challenges
Table 178. Protein Inhibitors Market Restraints
Table 179. Research Programs/Design for This Report
Table 180. Key Data Information from Secondary Sources
Table 181. Key Data Information from Primary Sources
List of Figures
Figure 1. Protein Inhibitors Product Picture
Figure 3. Global Protein Inhibitors Market Share by Type in 2021 & 2028
Figure 3. Protein Kinase Inhibitors Product Picture
Figure 4. Monoclonal Antibody Product Picture
Figure 5. Others Product Picture
Figure 6. Global Protein Inhibitors Market Share by Application in 2021 & 2028
Figure 7. Oncology
Figure 8. Inflamatory Diseases
Figure 9. Others
Figure 10. Protein Inhibitors Report Years Considered
Figure 11. Global Protein Inhibitors Sales 2017-2028 (K Units)
Figure 12. Global Protein Inhibitors Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Protein Inhibitors Revenue 2017-2028 (US$ Million)
Figure 14. Global Protein Inhibitors Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global Protein Inhibitors Sales Market Share by Region (2017-2022)
Figure 16. Global Protein Inhibitors Sales Market Share by Region (2023-2028)
Figure 17. North America Protein Inhibitors Sales YoY (2017-2028) & (K Units)
Figure 18. North America Protein Inhibitors Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Europe Protein Inhibitors Sales YoY (2017-2028) & (K Units)
Figure 20. Europe Protein Inhibitors Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Asia-Pacific Protein Inhibitors Sales YoY (2017-2028) & (K Units)
Figure 22. Asia-Pacific Protein Inhibitors Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Latin America Protein Inhibitors Sales YoY (2017-2028) & (K Units)
Figure 24. Latin America Protein Inhibitors Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Middle East & Africa Protein Inhibitors Sales YoY (2017-2028) & (K Units)
Figure 26. Middle East & Africa Protein Inhibitors Revenue YoY (2017-2028) & (US$ Million)
Figure 27. The Protein Inhibitors Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 28. The Top 5 and 10 Largest Manufacturers of Protein Inhibitors in the World: Market Share by Protein Inhibitors Revenue in 2021
Figure 29. Global Protein Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 30. Global Protein Inhibitors Sales Market Share by Type (2017-2028)
Figure 31. Global Protein Inhibitors Revenue Market Share by Type (2017-2028)
Figure 32. Global Protein Inhibitors Sales Market Share by Application (2017-2028)
Figure 33. Global Protein Inhibitors Revenue Market Share by Application (2017-2028)
Figure 34. North America Protein Inhibitors Sales Market Share by Type (2017-2028)
Figure 35. North America Protein Inhibitors Revenue Market Share by Type (2017-2028)
Figure 36. North America Protein Inhibitors Sales Market Share by Application (2017-2028)
Figure 37. North America Protein Inhibitors Revenue Market Share by Application (2017-2028)
Figure 38. North America Protein Inhibitors Sales Share by Country (2017-2028)
Figure 39. North America Protein Inhibitors Revenue Share by Country (2017-2028)
Figure 40. United States Protein Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 41. Canada Protein Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 42. Europe Protein Inhibitors Sales Market Share by Type (2017-2028)
Figure 43. Europe Protein Inhibitors Revenue Market Share by Type (2017-2028)
Figure 44. Europe Protein Inhibitors Sales Market Share by Application (2017-2028)
Figure 45. Europe Protein Inhibitors Revenue Market Share by Application (2017-2028)
Figure 46. Europe Protein Inhibitors Sales Share by Country (2017-2028)
Figure 47. Europe Protein Inhibitors Revenue Share by Country (2017-2028)
Figure 48. Germany Protein Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 49. France Protein Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 50. U.K. Protein Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 51. Italy Protein Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 52. Russia Protein Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 53. Asia Pacific Protein Inhibitors Sales Market Share by Type (2017-2028)
Figure 54. Asia Pacific Protein Inhibitors Revenue Market Share by Type (2017-2028)
Figure 55. Asia Pacific Protein Inhibitors Sales Market Share by Application (2017-2028)
Figure 56. Asia Pacific Protein Inhibitors Revenue Market Share by Application (2017-2028)
Figure 57. Asia Pacific Protein Inhibitors Sales Share by Region (2017-2028)
Figure 58. Asia Pacific Protein Inhibitors Revenue Share by Region (2017-2028)
Figure 59. China Protein Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 60. Japan Protein Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 61. South Korea Protein Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 62. India Protein Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 63. Australia Protein Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 64. China Taiwan Protein Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 65. Indonesia Protein Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 66. Thailand Protein Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 67. Malaysia Protein Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 68. Latin America Protein Inhibitors Sales Market Share by Type (2017-2028)
Figure 69. Latin America Protein Inhibitors Revenue Market Share by Type (2017-2028)
Figure 70. Latin America Protein Inhibitors Sales Market Share by Application (2017-2028)
Figure 71. Latin America Protein Inhibitors Revenue Market Share by Application (2017-2028)
Figure 72. Latin America Protein Inhibitors Sales Share by Country (2017-2028)
Figure 73. Latin America Protein Inhibitors Revenue Share by Country (2017-2028)
Figure 74. Mexico Protein Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 75. Brazil Protein Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 76. Argentina Protein Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 77. Middle East and Africa Protein Inhibitors Sales Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Protein Inhibitors Revenue Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Protein Inhibitors Sales Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Protein Inhibitors Revenue Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Protein Inhibitors Sales Share by Country (2017-2028)
Figure 82. Middle East and Africa Protein Inhibitors Revenue Share by Country (2017-2028)
Figure 83. Turkey Protein Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 84. Saudi Arabia Protein Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 85. UAE Protein Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 86. Protein Inhibitors Value Chain
Figure 87. Protein Inhibitors Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed

---